01 2Gowling Lafleur Henderson LLP
02 3Gowling Lafleur Henderson LLP
01 52188835
01 2OSELTAMIVIR PHOSPHATE
02 3Oseltamivir Phosphate
01 1CAPSULE
02 2Capsule
03 1POWDER FOR SUSPENSION
04 1Powder for Oral Suspension
01 52016-02-26
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Brand Name : TAMIFLU
Patent Number : 2188835
Filing Date : 1996-02-26
Strength per Unit : 75mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Brand Name : TAMIFLU
Patent Number : 2188835
Filing Date : 1996-02-26
Strength per Unit : 12mg / mL
Dosage Form : Powder for Oral Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Brand Name : TAMIFLU
Patent Number : 2188835
Filing Date : 1996-02-26
Strength per Unit : 45mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Brand Name : TAMIFLU
Patent Number : 2188835
Filing Date : 1996-02-26
Strength per Unit : 6 mg / mL
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
Brand Name : TAMIFLU
Patent Number : 2188835
Filing Date : 1996-02-26
Strength per Unit : 30 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-02-26
Date Granted : 2006-08-08
LOOKING FOR A SUPPLIER?
